Sehgal I S, Dhooria S, Behera D, Agarwal R
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India. mail:
Eur Ann Allergy Clin Immunol. 2016 May;48(3):99-102.
Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder that results from immune responses mounted against antigens of Aspergillus fumigatus, resulting in non-specific respiratory symptoms and structural lung damage. Classically defined in individuals suffering from bronchial asthma and cystic fibrosis, ABPA has recently been described in other lung diseases including COPD, pulmonary tuberculosis, idiopathic bronchiectasis and others. Herein, we report the first case of ABPA complicating Swyer-James-Macleod's syndrome that was successfully treated with oral antifungal therapy.
变应性支气管肺曲霉病（ABPA）是一种肺部疾病，由针对烟曲霉抗原的免疫反应引起，导致非特异性呼吸道症状和肺部结构损伤。ABPA传统上定义于患有支气管哮喘和囊性纤维化的个体，最近在其他肺部疾病中也有描述，包括慢性阻塞性肺疾病（COPD）、肺结核、特发性支气管扩张等。在此，我们报告首例并发斯怀尔-詹姆斯-麦克劳德综合征的ABPA病例，该病例通过口服抗真菌治疗成功治愈。
